Dr Reddy's Swings To Profits In FQ4

Drugmaker Dr Reddy's Laboratories (NYSE: RDY) said that it swung to profits of $37 million, or $0.20 a share, in its fiscal fourth quarter, as compared to a loss of $218 million, or $1.30 a share, in the same quarter a year ago. RDY’s revenues fell 17% to $365 million. The company’s adjusted net profits after tax came in at $43 million.

India-based RDY has announced its final dividend of 225% or Rs.11.25 per share for the year ended March 31, 2010. Over the year, the company launched 103 new generic products and filed 121 new product registrations and registered 36 drug master files (DMFs) across the globe.

RDY fell 0.65% to close at $27.69 yesterday.

Read more from Benzinga's Markets.